Diagnosis & treatment - page 5

Alzheimer's disease (AD) is a major public health problem. According to the Alzheimer's Association, about 6.2 million people are living with the disease in the USA alone, and that number is projected to rise to nearly 14 million by 2050. Classic treatment eliminates symptoms and does not affect the underlying cause of the...

Immunotherapy is considered one of the most rapidly developing areas of oncology. For most cancers, doctors already use immune checkpoint inhibitors, and they have become part of standard cancer treatment. Monoclonal antibodies, antibody-drug conjugates, and CAR T-cell therapy are successfully used for some oncological...

Stem cells represent undifferentiated structures. Stem cells form more mature cells of different tissues in the process of growing. This depends on which biologically active compounds (growth factors) influence them, as well as on the presence of other organs and the number of tissues. These features of stem cells make stem cell...

Breast cancer immunotherapy is a modern treatment method that has demonstrated effectiveness in all stages of oncology. Thanks to the addition of immunotherapy to the usual treatment protocol, doctors in Germany achieve excellent results in the treatment of metastatic and triple-negative breast cancer, as well as relapses of oncology. 

A soft tissue sarcoma is a malignant, non-epithelial tumor. Such tumors may arise from muscles, adipose tissue, cartilage tissue, blood vessels, skin, etc. Sarcomas differ from cancer in that they do not grow from the epithelium. These are relatively rare tumors. They can develop in any part of the body. 

Dendritic cell breast cancer treatment is effective in almost all patients, since after vaccination, a patient’s own anti-cancer immunity is activated. Individually manufactured vaccines with dendritic cells improve the results of treatment in different clinical situations: after surgery to remove a tumor, in the lymph nodes affection...

One of the peculiarities of human immunity is the ability to distinguish healthy cells from malignant ones in order to attack and destroy the latter. In brain tumors, this is especially important because surgeons cannot remove a large amount of brain tissue, and radiation therapy and chemotherapy are often not effective enough. 

Adrenal cancer is a rare but very aggressive tumor. According to clinical statistics, it usually develops in people over 40 years old. More than half of the patients amongst these people are women. Since the adrenal glands are endocrine organs, the tumor is hormonally active in every 2 out of 3 patients. German hospitals use innovative...